Y Intercept (Hong Kong) LTD Emergent Bio Solutions Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.86 - $6.98 $30,193 - $113,306
16,233 New
16,233 $110,000
Q3 2023

Nov 14, 2023
BUY
$3.17 - $7.91 $238,897 - $596,113
75,362 New
75,362 $256,000
Q4 2022

Feb 14, 2023
BUY
$11.0 - $21.45 $97,141 - $189,424
8,831 Added 58.18%
24,009 $283,000
Q3 2022

Feb 14, 2023
BUY
$20.09 - $35.8 $304,926 - $543,372
15,178 New
15,178 $318,000

Others Institutions Holding EBS

# of Institutions
159
Shares Held
33.7M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $463M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email